Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 86 | 99 | +13 |
| Shares | 24.8M | 26.8M | +2.00M (+8.1%) |
| Value | $395.7M | $590.4M | +$194.7M (+49.2%) |
New holders (28)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (15)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Frazier Management LLC | 3,566,912 | $56.9M |
| BVF Inc | 435,936 | $6.95M |
| AIGH Capital Management LLC | 337,917 | $5.39M |
| Chartwell Investment Partners, LLC | 91,490 | $1.46M |
| Worth Venture Partners, LLC | 77,515 | $1.24M |
| Marshall Wace, LLP | 52,527 | $839.0K |
| ExodusPoint Capital Management, LP | 52,474 | $837.0K |
| Public Employees Retirement System of Ohio | 26,223 | $418.0K |
| Los Angeles Capital Management LLC | 21,575 | $344.0K |
| Rothschild Investment Corp | 15,500 | $247.0K |
| Congress Wealth Management LLC | 10,000 | $160.0K |
| UBS Group AG | 2,481 | $39.0K |
| Simplex Trading, LLC | 1,108 | $17.0K |
| Aquatic Capital Management LLC | 700 | $11.0K |
| Wells Fargo & Company | 21 | $0 |